Suggested Citation: "5 Sampling and Estimation." National Academies of Sciences, Engineering, and Medicine. 2018. Reengineering the Census Bureau's Annual Economic Surveys. Washington, DC: The ...
The customary approach to early-phase clinical trial design, where the focus is on identification of the maximum tolerated dose, is not always suitable for noncytotoxic or other targeted therapies.